ABVC BioPharma Inc.

NASDAQ: ABVC · Real-Time Price · USD
3.08
0.23 (8.07%)
At close: Aug 20, 2025, 1:27 PM

ABVC BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
248.38K 60.16K 85.27K 5.83M
Short-Term Investments
64.74K 79.31K 75.8K 108.15K
Long-Term Investments
2.26M 2.53M 842.07K 932.75K
Other Long-Term Assets
1.95M 1.53M 4.17M 160.47K
Receivables
1.16M 759.57K 1.37M 1.71M
Inventory
n/a n/a 1.31M 25.98K
Other Current Assets
711.65K 757.68K n/a 736.67K
Total Current Assets
2.18M 1.66M 2.99M 9.63M
Property-Plant & Equipment
1.15M 8.78M 1.74M 2M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
5.36M 12.84M 6.87M 4.07M
Total Assets
7.54M 14.49M 9.86M 13.7M
Account Payables
n/a n/a n/a n/a
Deferred Revenue
81.11K 79.5K 10.98K 10.98K
Short-Term Debt
2.55M 1.47M 1.89M 1.64M
Other Current Liabilities
-462.25K 2.51M 468.15K n/a
Total Current Liabilities
6.56M 5.93M 5.54M 3.69M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
21.68K 21.68K 7.98K 10.58K
Total Long-Term Liabilities
258.49K 429.14K 799.81K 1.14M
Total Liabilities
6.82M 6.36M 6.24M 4.83M
Total Debt
3.2M 2.28M 3.05M 3.11M
Common Stock
13.87K 7.94K 3.29K 28.93K
Retained Earnings
-68.95M -65.42M -54.9M -38.48M
Comprehensive Income
445.67K 516.39K 517.13K 539.66K
Shareholders Equity
1.23M 8.39M 3.1M 8.84M
Total Investments
2.32M 2.61M 917.87K 1.04M